Merck & Co., Inc. – Economic Business Analysis

2464 Words10 Pages
Merck & Co., Inc. – Economic Business Analysis Lola Bryant Management/521 September 20, 2012 Dr. Gary Harris Merck & Co., Inc. – Economic Business Analysis The economic business analysis of Merck & Co., Inc. will review the strategic initiatives taken to be organizationally and operationally adaptive in changing markets. It will provide an overview of the economic downturns experienced in the past five years. Demonstrating the company’s adaptive strategies, the analysis will present examples of effective initiatives the company adopted during these periods. In addition the analysis will discuss future implementation strategies to manage the effects of current economic trends on the company. Merck & Co., Inc. is a publically traded pharmaceutical company. It emphasizes operations in five areas: prescription drugs, biologic therapies, vaccines, consumer care products and animal health (Merck, 2012, p.1). The corporate headquarters are in Whitehouse Station, NJ, and there are 120 facilities globally with approximately 91,000 employees (BMI, 2012, p.75). The company reported revenues in Fiscal Year 2011 were $48,047 million and a net profit of $6,272 million (MarketLine Report, 2012). Economics Economic conditions can affect businesses in many ways. The basic concept of economics is how a country takes it resources, makes something, and distributes it to others for consumption. Global economics and politics play a vital role in today’s market because so many companies participate in free trade. It is very important to stay informed of global and national economics to be competitive (Nickels, 2012, p.30). Business is not only for the business owner, it also contributes to the economic growth of the community in which it operates. The company generates jobs and those employees spend money within the community. The company may
Open Document